Breaking News

Richter-Helm Triples cGMP Production Capacity

Will invest close to €70 million to triple current biologic production capacity and expand existing warehouse, lab, and administration buildings.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Richter-Helm BioLogics GmbH & Co. KG, a German CDMO, began construction for an expansion at its cGMP manufacturing facility in Bovenau, Germany. The new multi-product biologics manufacturing facility is expected to begin full-scale operations and manufacturing by the end of 2023.   The basic engineering of the new facility has been completed and the ground-breaking ceremony took place on May 5th, 2021 by the management team of Richter-Helm, who initiated construction of the new facility. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters